Vestcor Inc’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,385
Closed -$294K 1249
2025
Q3
$294K Buy
10,385
+6,687
+181% +$181K 0.01% 883
2025
Q2
$92K Buy
+3,698
New +$104K ﹤0.01% 1071
2024
Q2
Sell
-5,483
Closed -$230K 1291
2024
Q1
$230K Buy
+5,483
New +$214K 0.01% 923
2023
Q4
Sell
-4,118
Closed -$127K 1316
2023
Q3
$127K Buy
+4,118
New +$142K ﹤0.01% 1087
2023
Q2
Sell
-6,736
Closed -$246K 1189
2023
Q1
$246K Sell
6,736
-1,900
-22% -$66.5K 0.01% 822
2022
Q4
$256K Buy
+8,636
New +$278K 0.01% 836
2020
Q4
Sell
-953
Closed -$17K 1030
2020
Q3
$17K Hold
953
﹤0.01% 892
2020
Q2
$16K Buy
+953
New +$15K ﹤0.01% 829

Other funds holding ASTH

Vestcor Inc's ASTH Position: Q4 2025 in Review

Vestcor Inc sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 10,385 shares — an estimated $294K sold.

Vestcor Inc first reported a position in ASTH in Q2 2020 and held it in 8 quarters. The position peaked at $294K in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Vestcor Inc reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Vestcor Inc sold 10,385 Astrana Health shares in Q4 2025, an estimated $294K.
  • Vestcor Inc first reported a position in Astrana Health in Q2 2020 and held it in 8 quarters.
  • Vestcor Inc's Astrana Health position peaked at $294K in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Vestcor Inc's 13F filing for Q4 2025, filed 11 Feb 2026.